Using 18F-DCFPyL Prostate-Specific Membrane Antigen–Directed Positron Emission Tomography/Magnetic Resonance Imaging to Define Intraprostatic Boosts for Prostate Stereotactic Body Radiation Therapy

Using 18F-DCFPyL Prostate-Specific Membrane Antigen–Directed Positron Emission Tomography/Magnetic Resonance Imaging to Define Intraprostatic Boosts for Prostate Stereotactic Body Radiation Therapy

Purpose: The recently reported FLAME trial demonstrated a biochemical disease-free survival benefit to using a focal intraprostatic boost to multiparametric magnetic resonance imaging (mpMRI)–identified lesions in men with localized prostate cancer treated with definitive radiation therapy. Prostate...

Full description

Bibliographic Details
Main Authors:	John M. Floberg, MD, PhD, Shane A. Wells, MD, Diane Ojala, CMD, R. Adam Bayliss, PhD, Patrick M. Hill, PhD, Brett A. Morris, MD, PhD, Zachary S. Morris, MD, PhD, Mark Ritter, MD, PhD, Steve Y. Cho, MD
Format:	Article
Language:	English
Published:	Elsevier 2023-09-01
Series:	Advances in Radiation Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2452109423000702

Similar Items

Use of Stereotactic Magnetic Resonance-Guided Online Adaptive Radiation Therapy for Treatment of a Pelvic Recurrence of Prostate Cancer in a Patient With an Orthotopic Neobladder
by: John M. Floberg, MD, PhD, et al.
Published: (2022-09-01)

Automated Planning for Prostate Stereotactic Body Radiation Therapy on the 1.5 T MR-Linac
by: Stefania Naccarato, PhD, et al.
Published: (2022-05-01)

Factors Affecting Prostate Displacement During Volumetric Modulated Arc Therapy in Prone Position After High-Dose-Rate Brachytherapy for Prostate Cancer
by: Takayuki Sakurai, MD, PhD, et al.
Published: (2023-11-01)

Carbon Ion Radiation Therapy for Nonmetastatic Castration-Resistant Prostate Cancer: A Retrospective Analysis
by: Yuhei Miyasaka, MD, PhD, et al.
Published: (2024-04-01)

First-in-Men Online Adaptive Robotic Stereotactic Body Radiation Therapy: Toward Ultrahypofractionation for High-Risk Prostate Cancer Patients
by: Victor J. Brand, MD, et al.
Published: (2025-02-01)

Recent Advances and Challenges in Stereotactic Body Radiotherapy
by: Atsuto Katano MD, PhD, et al.
Published: (2024-02-01)

Simulation of an HDR “Boost” with Stereotactic Proton versus Photon Therapy in Prostate Cancer: A Dosimetric Feasibility Study
by: Jill S. Remick, MD, et al.
Published: (2020-11-01)

Magnetic Resonance–Guided Prostate Stereotactic Body Radiation Therapy With Daily Online Plan Adaptation: Results of a Prospective Phase 1 Trial and Supplemental Cohort
by: Jonathan E. Leeman, MD, et al.
Published: (2022-09-01)

A Phase I/II Study of Ultra-Hypofractionated Carbon-ion Radiation therapy for Low- and Intermediate-Risk Localized Prostate Cancer
by: Noriyuki Okonogi, MD, PhD, et al.
Published: (2025-03-01)

Single fraction stereotactic radiosurgery for multiple brain metastases
by: Dror Limon, MD, et al.
Published: (2017-10-01)

The Emerging and Promising Role of Care for Cardiometabolic Syndrome in Prostate Cancer
by: Atsushi Tanaka, MD, PhD, et al.
Published: (2019-12-01)

A Single-Institution Prospective Study To Evaluate the Safety and Efficacy of Real- Time Image-Gated Spot-Scanning Proton Therapy (RGPT) for Prostate Cancer
by: Kentaro Nishioka, MD, PhD, et al.
Published: (2024-05-01)

Prognostic role of preoperative fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography with an image-based harmonization technique: A multicenter retrospective studyCentral MessagePerspective
by: Akira Hamada, MD, PhD, et al.
Published: (2023-06-01)

Prostate-Specific Membrane Antigen PET Response Associates with Metastasis-Free Survival After Stereotactic Ablative Radiation in Oligometastatic Prostate Cancer
by: Philip Sutera, MD, et al.
Published: (2024-07-01)

A Phase I/II Trial of Fairly Brief Androgen Suppression and Stereotactic Radiation Therapy for High-Risk Prostate Cancer (FASTR-2): Preliminary Results and Toxicity Analysis
by: Laura Callan, MD, MASc, et al.
Published: (2019-10-01)

Prostate International, an international academic forum on prostate diseases
by: Choung-Soo Kim, MD, PhD
Published: (2013-03-01)

Effect of Target Changes on Target Coverage and Dose to the Normal Brain in Fractionated Stereotactic Radiation Therapy for Metastatic Brain Tumors
by: Hideharu Miura, PhD, et al.
Published: (2023-11-01)

Fluorodeoxyglucose positron emission tomography (FDG/PET) shows the effect of carbon-ion radiotherapy (CIRT); with pathologic confirmation
by: Jun Aoki, MD, et al.
Published: (2023-05-01)

Cancer Research Line (CAREL): Development of Expanded Distributed Research Networks for Prostate Cancer and Lung Cancer
by: Jihwan Park PhD, et al.
Published: (2023-03-01)

Prostate-Centric Versus Bony-Centric Registration in the Definitive Treatment of Node-Positive Prostate Cancer with Simultaneous Integrated Boost: A Dosimetric Comparison
by: Trudy C. Wu, MD, et al.
Published: (2022-07-01)

Prostate Artery Embolization in the Setting of Prostate Cancer: Review and Opinion
by: Nainesh Parikh MD, MBA, et al.
Published: (2025-01-01)

Fluorodeoxyglucose-positron emission tomography as a potential alternative tool for functional diagnosis of glycogen storage disease type I
by: Takeshi Sato, MD, et al.
Published: (2023-01-01)

Extragastrointestinal stromal tumor presenting as an exophytic prostatic mass
by: Thao Nguyen Thanh, MD, PhD, et al.
Published: (2020-08-01)

Dosimetric and Hematologic Implications of Prostate-Only Versus Whole Pelvic Radiotherapy: Results of the Multicentric Phase 3 PROPER Study
by: Valérie Fonteyne MD, PhD, et al.
Published: (2023-04-01)

Early Detection of Leptomeningeal Metastases Among Patients Undergoing Spinal Stereotactic Radiosurgery
by: Morgan E. Freret, MD, PhD, et al.
Published: (2023-03-01)

Assessment of Sexual Outcomes in Patients Undergoing Thulium Laser Prostate Surgery for Management of Benign Prostate Hyperplasia: A Systematic Review and Meta-analysis
by: Bibo Li, PhD, MD, et al.
Published: (2022-04-01)

Ultrahypofractionated Radiation Therapy for Prostate Cancer Including Seminal Vesicles in the Target Volume: A Treatment-planning Study Based on the HYPO-RT-PC Fractionation Schedule
by: Elinore Wieslander, PhD, et al.
Published: (2024-07-01)

Imaging Neurotensin Receptor in Prostate Cancer With Cu-Labeled Neurotensin Analogs
by: Huaifu Deng MD, et al.
Published: (2017-08-01)

Successful surgery for secondary aortoduodenal fistula based on 18F-fluorodeoxyglucose positron emission tomography/computed tomography findings
by: Satoshi Sakakibara, MD, et al.
Published: (2023-06-01)

Outcomes in Patients with Intact and Resected Brain Metastasis Treated with 5-Fraction Stereotactic Radiosurgery
by: David J. Carpenter, MD, et al.
Published: (2023-03-01)

Impact of Stereotactic Body Radiotherapy on Thrombin Generation and Platelet Aggregation in Patients with Non-Small Cell Lung Cancer
by: Kristian Kirkelund Bentsen MD, et al.
Published: (2023-11-01)

Identification of Differently Expressed miRNAs and Genes between Benign Prostatic Hyperplasia and Prostate Cancer
by: Yuqing Huang, MD, Cui Lei, BS, Xinyu Zhao, PhD, Jing Xiao, PhD, Xian-Quan Shi, PhD
Published: (2024-03-01)

Association of Obesity and Smoking With PSA and PSA Velocity in Men With Prostate Cancer
by: Amit M. Algotar PhD, MBBS, et al.
Published: (2011-05-01)

Safety and Feasibility of Stereotactic Radiosurgery for Patients with 15 or more Brain Metastases
by: Rituraj Upadhyay, MD, et al.
Published: (2024-07-01)

Local Graft Irradiation for Acute, Medication Refractory Transplant Rejection of a Pancreas Alone Graft: A Case Report
by: Brett A. Morris, MD, PhD, et al.
Published: (2023-03-01)

Assessing the Optimum Use of Androgen-Deprivation Therapy in High-Risk Prostate Cancer Patients Undergoing External Beam Radiation Therapy
by: Michelle S. Ludwig MD, MPH, PhD, et al.
Published: (2017-01-01)

Effect of Time-of-Flight and Regularized Reconstructions on Quantitative Measurements and Qualitative Assessments in Newly Diagnosed Prostate Cancer With F-Fluorocholine Dual Time Point PET/MRI
by: Spencer C. Behr MD, et al.
Published: (2017-11-01)

Cervical lymph node metastasis as the first and only manifestation of prostatic adenocarcinoma
by: Tadashi Terada, MD, PhD
Published: (2015-12-01)

Comparing Perspectives of Canadian Men Diagnosed With Prostate Cancer and Health Care Professionals About Active Surveillance
by: Margaret Fitch PhD, et al.
Published: (2020-12-01)

Dosimetric Evaluation of PSMA PET-Delineated Dominant Intraprostatic Lesion Simultaneous Infield Boosts
by: Christopher D. Goodman, MD, et al.
Published: (2020-03-01)